Orally active microtubule-targeting agent, MPT0B271, for the treatment of human non-small cell lung cancer, alone and in combination with erlotinib

por Tsai, A-C, Wang, C-Y, Liou, J-P, Pai, H-C, Hsiao, C-J, Chang, J-Y, Wang, J-C, Teng, C-M, Pan, S-L
Publicado 2014